Health Delivery Performance

Journal of General Internal Medicine

Ge Bai for Health Affairs Forefront

Jennifer Wolff and Casey Overby Taylor for Journal of American Geriatrics Society

Ellesse-Roselee L. Akré and Nicholas S. Reed for JAMA Health Forum

Tej D. Azad, Rachel J. Wu, Kelly E. Anderson, Michael Darden & Amit Jain for Osteoporosis International

Risa Wolf for Clinical Diabetes

Vadim Dukhanin and Kathryn McDonald for PEC Innovation

Hossein Zare and Gerard Anderon for the Journal of Healthcare Management

Melinda Buntin for Health Affairs Scholar

Jodi Segal, Maqbool Dada and K. Davina Frick for Medical Care

Shaker Eid for Quality Management in Health Care

Olga Yakusheva for Nursing Outlook

Ge Bai for Health Affairs

Yimin Ge and Matthew Eisenberg for Health Affairs Scholar

Tinglong Dai for the National Bureau of Asian Research

Ge Bai for JAMA Health Forum

Eric Slade and Laura Samuel for Medical Care Research and Review

Fireside chat between HBHI's Director and Bloomberg Distinguished Professor, Dan Polsky, PhD and Ziad ​Obermeyer, MD, Blue Cross of California Distinguished Associate Professor, Health Policy and Management, University of California, Berkeley

The panel, moderated by Mario Macis, PhD, Professor at Johns Hopkins University, included Andrew Cameron, MD, Director of Johns Hopkins School of Medicine Dept of Surgery; Alexandra Glazier, CEO, New England Donor Services; Jean Moody-Williams, RN, MPP, Deputy Center Director for CMS; Denis Wagner, MPA, Principal and Director of YES and Leadership, LLC

HBHI is pleased to announce our six pilot grant awardees for our 2025 cohort.

Albert Wu for Journal of Patient Safety and Risk Management

Phillip Phan for BMJ Open

You’re invited to access this exclusive FMG Leading/Fierce Healthcare panel discussion featuring HBHI Director Dan Polsky to learn more.

The panel, moderated by Andrew Anderson, PhD, Assistant Professor at Johns Hopkins University, included Andy Higgins, VP of Product Development at Clever Care; Sachin Jain, CEO of SCAN Group and SCAN Health Plan; Mark Meiselbach, Assistant Professor at Johns Hopkins University; and Casey Schwarz, Senior Counsel for Federal Policy.

Ravi Gupta and G Caleb Alexander for Health Affairs Scholar

Albert Wu and Kathryn McDonald in Journal of Patient Safety and Risk Management

Risa Wolf in JAMA Network Open

Angela Liu Kelly E. Anderson, Joseph Levy, Daniel Polsky, and Gerard Anderson in JAMA Health Forum

Featured speaker Dr. Nigam Shah from Stanford discussed the importance of aligning AI models with healthcare realities, particularly around capacity constraints and financial sustainability.

The panel, moderated by Bruce Leff, MD, Professor of Medicine at Johns Hopkins, included Ali Khan, MD, MPP, FACP, Vice President and Chief Medical Officer – Aetna Medicare, Aetna/CVS Health Company; Eliza Pippa Shulman, DO, MPH, Chief Medical Officer at Medically Home; and Kristofer L. Smith, MD, MPP, Past-Chief Medical Officer at Optum at Home.

HBHI and the Center for Health Systems and Policy Models (CHSPM) invited a panel of three guests to discuss this issue: Senator Richard Burr, Chair of DLA Piper’s health policy strategic consulting service; Michael Darden, PhD, academic program director for the Master of Science in healthcare management at the Carey School of Business; and Lauren Taylor, professor in the Department of Population Health at NYU Grossman School of Medicine.

HBHI convened an expert panel at the Hopkins Bloomberg Center in Washington, D.C. to discuss how the healthcare industry at large and providers at the grassroots level are working to bring about change.

A new report by the National Academies of Sciences, Engineering, and Medicine examines the current challenges in increasing the behavioral health care workforce capacity to better meet the needs of publicly insured populations and proposes strategies to address those challenges.

Significant variation in coding intensity among hospitals has been observed and can lead to reimbursement inequities and inadequate risk adjustment for quality measures.

The United States is experiencing a decline in life expectancy despite high health care spending due to a multitude of factors, including the COVID-19 pandemic, opioid epidemic, high burden of chronic disease, and systemic and structural inequities.

Congratulations to Johns Hopkins University Carey Business School Professors and HBHI Core Faculty members Shubhranshu Singh and Tinglong Dai on their recently accepted paper.

The American healthcare system, an intricate web of providers, insurers, patients, and employers, has failed to improve meaningfully, despite decades of medical discovery and technological advancement, but has also become increasingly expensive. Why?

Featuring Expert Panelists Jeremey Greene, MD, PhD and Jodi Sherman, MD

The annual cost of hospital care services in the US has risen to over $1 trillion despite relatively worse health outcomes compared to similar nations.

The adoption of predictive algorithms in healthcare comes with the potential for algorithmic bias, which could exacerbate existing disparities.

Academic medical practices serve a valuable role in caring for patients with complex needs and training future internists in the many biopsychosocial components of patient care.

Health care overuse is pervasive in countries with advanced health care delivery systems

The overuse of some medical services remains a chronic problem in the United States

Do companies have a responsibility for the health consequences of their products? Should those consequences drive how a company designs its product or service to be used by customers? What are the tradeoffs?

The goal of this webinar is to discuss the ecosystem of markets for blood and blood components in the US, the structure of the market ecosystem, the challenges faced, and the steps underway to address the challenges and ensure a stable supply of blood and blood components for patients in need.

Why doesn't healthcare in the US improve in quality while becoming more affordable, as we see in other industries? Join us for an enlightening discussion with James (Jim) and Robert (Bob) Rebitzer, authors of "Why Not Better and Cheaper?"

The Hopkins Healthcare Business Conference is a student produce event aiming to stimulate intellectual engagement, foster active participation, and provide robust networking opportunities for graduate students, academics, and industry leaders. The conference is centered on a commitment to multi-sectoral collaboration to support effective and equitable healthcare innovation. March 7th and 8th

A unique feature of health care markets, recognized by Arrow (1963), is that a physician, the supplier of medical services, is expected to act in the patient’s best interest.

Hospitalization is the standard of care for acute illness, but hospital care is often expensive, unsafe, and uncomfortable (1).

Patients with cancer face a crisis due to an ongoing shortage of essential chemotherapeutic drugs.

The application of psychedelic therapy for a range of mental and physical health issues is emerging as a transformative treatment method but federal policy has not kept pace with the industry’s rapid development. To understand the burgeoning business landscape surrounding this innovative therapy, the Hopkins Business of Health Initiative, in partnership with the Center for Mental Health and Addiction Policy, recently convened a panel of national experts to discuss the cutting-edge convergence of psychedelics, business, and policy.  

Professor Nicholson Price, J.D., Ph.D., Professor of Health, University of Michigan Law School

Professor Danton Char, Stanford University School of Medicine; Faculty Affiliate, Institute for Human-Centered Artificial Intelligence (HAI)

HBHI is pleased to announce our five pilot grant awardees for our 2024 cohort.

Why doesn't healthcare in the US improve in quality while becoming more affordable, as we see in other industries? Join us for an enlightening discussion with James (Jim) and Robert (Bob) Rebitzer, authors of "Why Not Better and Cheaper?" We explored the unique challenges of healthcare innovation in the US, discussing why there's a lack of incentives for cost-reducing innovations and the ease of profiting from low-value innovations. The Rebitzers also shared their perspectives on directing healthcare innovation towards more efficient and cost-effective solutions. This is a crucial conversation for anyone interested in the future of American healthcare.

Non-compete agreements typically restrict employees from joining competitors or starting similar businesses within a given timeframe and geographical area after leaving their jobs. These kinds of covenants have become enormously widespread in the American economy, and even more so in the sector of health care. 

Policy makers and insurers promote the use of generic drugs because they can deliver large savings without sacrificing quality. But these efforts meet resistance from the public, who perceive generic drugs as inferior substitutes for brand name counterparts. Building on literature showing that negative emotions reduce risk-taking, the authors hypothesize that receiving bad medical news (i.e., negative information about one’s health) prompts patients to favor brand name over generic drugs as means to safeguard their health. The evidence exploits low-density lipoprotein cholesterol test results, where a discontinuity from clinical guidelines enables the authors to estimate the causal effect of bad medical news.

Diagnostic effort, diagnostic testing, physician payment, healthcare operations management, artificial intelligence

Public pay-for-performance (P4P) programs tie hospital payments to predetermined sets of quality measures and are intended to encourage or discourage certain outcomes

Since the 2007 landmark report on Preventing Medication Errors from the US National Academy of Medicine, effective interventions have been developed to address medication errors.1 Despite this, medication errors persist as the most common source of harm for patients worldwide.2 In hospitals, adverse drug events are the most common adverse events, accounting in one large study for 39% of all events.3 Medication errors in ambulatory care settings are also an ongoing patient safety challenge.4

It’s clear that changes in telehealth policy, mobile technology development, and consumer demand have fundamentally reshaped mental health treatment and substance use care in the US and around the world. What does this mean for people’s outcomes, specifically behavioral health care access, quality, and cost?

Despite growth in private equity (PE) acquisitions of physician practices in the US, little is known about how changes in ownership influence workforce composition. Using clinician-level data linked to practice acquisition information, we estimated changes in clinician workforce composition in PE-acquired practice sites relative to non-PE-acquired independent practice sites for dermatology, ophthalmology, and gastroenterology specialties.

Around 150 million Americans rely on employers for access to health care. Can the companies who employ them help foster an affordable system that improves our health and doesn't drive us crazy in the process?

In this cohort study of nursing homes experiencing severe COVID-19 outbreaks, facilities experienced considerable staffing challenges during and after outbreaks. These results suggest the need for policy action to ensure facilities’ abilities to maintain adequate staffing levels during and after infectious disease outbreaks.

Despite varying levels of non-profit hospital community benefit investment across counties, higher community benefit expenditures are not associated with an improvement in the selected health outcomes at the county level.

The proposal for a national PrEP program applies some of the lessons of the national COVID vaccine campaign to HIV prevention.

Elective surgical suspension during the COVID-19 pandemic resulted in a sizeable surgical case backlog throughout the world. As we ramp back up, how do we decide which cases take priority?

Hospitals with a greater number of beds and fewer primary care physicians are more likely to provide unnecessary medical tests or treatments, according to a study led by researchers at the Johns Hopkins School of Medicine and Bloomberg School of Public Health